Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
680000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 11th stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数680,000Shares
680,000 shares (new shares)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Existing Shares and Increase
+0.90%Rate of increase
89,855,233 shares90,535,233Shares
0.9% (exercise ratio subject to exercise restrictions; 680,000 shares delivered / 75,355,233 listed shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥30 (exercise price on 20 and 21 August 2026). Details of the adjustment clause and the floor: not disclosed
Number of Stock Acquisition Rights
Total issued: 700,000; exercised during the target month: 6,800; unexercised at the end of the target month: 548,200
Procedures under the Corporate Code of Conduct
As part of the status of compliance with exercise restrictions, the disclosure describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments
Most recent equity financing
Timing 26 December 2025 / Type Issuance of the 11th and 12th stock acquisition rights / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 11th stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 680,000 shares (new shares) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | 0.9% (exercise ratio subject to exercise restrictions; 680,000 shares delivered / 75,355,233 listed shares) |
| Total number of issued shares | 89,855,233 shares (as of the end of the month preceding the target month) → 90,535,233 shares (as of the end of the target month, based on a simple calculation) |
| Exercise price | ¥30 (exercise price on 20 and 21 August 2026). Details of the adjustment clause and the floor: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 700,000; exercised during the target month: 6,800; unexercised at the end of the target month: 548,200 |
| Procedures under the Corporate Code of Conduct | As part of the status of compliance with exercise restrictions, the disclosure describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments |
| Most recent equity financing | Timing 26 December 2025 / Type Issuance of the 11th and 12th stock acquisition rights / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status. No other reason is stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.